Current evidence for the interventional treatment of INOCA patients

Supported by an educational grant from Neovasc

Session coordinator: S. Banai

Speakers: T. Gori, F. Giannini, C. Berry, S. Banai, C. Berry, F. Giannini, T. Gori

Summary

Watch this session if you want to understand how Reducer therapy can help the interventionalist safely improve symptoms of his "end stage" patient, to recognize that microvascular disease is common and has poor prognosis and to understand how Reducer therapy can address patients with microvascular disease.

Learning Objectives

To understand when Reducer therapy can be a tool for the interventionalist to improve symptoms of "end stage" patient with a low level of procedural risk
To recognise when a patient is diagnosed with "refractory angina" in the cathlab and understand how Reducer therapy can address these patients with a low level of procedural risk
To recognise when patients with angina and non obstructive CAD (ANOCA) are at a high level of prognostic risk